OR8J1 Antibody

What is OR8J1 and why is it relevant to scientific research?

OR8J1 (Olfactory Receptor Family 8 Subfamily J Member 1) is a member of the largest gene family in the genome - olfactory receptors. These are G-protein-coupled receptors (GPCRs) that interact with odorant molecules in the nasal epithelium to initiate neuronal responses for smell perception . OR8J1 is encoded by a single exon gene and shares the characteristic 7-transmembrane domain structure common to many neurotransmitter and hormone receptors . Research on OR8J1 is valuable for understanding:

• Olfactory signal transduction mechanisms

• GPCR structure-function relationships

• Potential ectopic expression in non-olfactory tissues

• Evolutionary aspects of chemosensory perception

What are the key specifications of commercially available OR8J1 antibodies?

Most commercial OR8J1 antibodies share these characteristics:

What is the recommended sample preparation for OR8J1 detection?

For optimal OR8J1 detection:

• Tissue samples: Flash-freeze immediately after collection and store at -80°C until processing. For olfactory epithelium, careful dissection is crucial to preserve receptor-expressing neurons.

• Cell lysis: Use RIPA buffer supplemented with protease inhibitors for most applications. For membrane proteins like OR8J1, consider using non-ionic detergents (e.g., NP-40 or Triton X-100) at concentrations that maintain protein structure.

• Protein estimation: Perform Bradford or BCA assay to ensure equal loading of samples.

• Sample denaturation: Heat protein samples at 95°C for 5 minutes in Laemmli buffer containing β-mercaptoethanol to reduce disulfide bonds, especially important for GPCRs like OR8J1 .

How should Western blot protocols be optimized for OR8J1 detection?

OR8J1 detection requires careful optimization due to its membrane protein nature:

• Protein loading: Load 20-50 μg total protein per lane for cell lysates; higher amounts may be needed for tissue samples with low expression.

• Gel percentage: Use 10-12% polyacrylamide gels to resolve OR8J1 (expected molecular weight ~35 kDa) .

• Transfer conditions:

  • Use PVDF membranes (rather than nitrocellulose) for better retention of hydrophobic proteins

  • Consider semi-dry transfer at 15-20V for 30-45 minutes or wet transfer at 30V overnight at 4°C

  • Add 0.1% SDS to transfer buffer to improve transfer efficiency of membrane proteins

• Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

• Antibody dilution: Prepare primary antibody at 1:500-1:2000 dilution in blocking buffer and incubate overnight at 4°C .

• Detection: Use highly sensitive chemiluminescent reagents due to potentially low expression levels of OR8J1 in some systems.

• Controls: Include both positive controls (Jurkat cells have been documented as expressing OR8J1) and negative controls.

What validation strategies confirm OR8J1 antibody specificity?

For rigorous validation:

• Peptide competition assay: Pre-incubate antibody with the immunizing peptide before application to samples. Signal elimination confirms specificity to the target epitope .

• Knockout/knockdown controls: Use OR8J1 knockout or siRNA-treated samples as negative controls .

• Multiple antibody approach: Compare results using antibodies targeting different OR8J1 epitopes .

• Cross-reactivity testing: Test against closely related olfactory receptors, particularly those in the OR8 family.

• Mass spectrometry confirmation: Perform immunoprecipitation followed by mass spectrometry to confirm the identity of the detected protein.

• Recombinant protein: Use purified OR8J1 recombinant protein as a positive control .

What are the critical considerations for immunofluorescence using OR8J1 antibodies?

For successful immunofluorescence:

• Fixation: Use 4% paraformaldehyde for 10-15 minutes; avoid over-fixation which may mask epitopes.

• Permeabilization: For this transmembrane protein, use 0.1-0.2% Triton X-100 for 5-10 minutes.

• Antigen retrieval: May be necessary for formalin-fixed tissues; try citrate buffer (pH 6.0) at 95°C for 20 minutes.

• Antibody dilution: Use 1:200-1:1000 for most OR8J1 antibodies .

• Incubation time: Extend primary antibody incubation to overnight at 4°C for improved signal-to-noise ratio.

• Counterstaining: Include DAPI nuclear counterstain and possibly other cellular markers to establish subcellular localization.

• Controls: Include secondary-only controls and tissue known to be negative for OR8J1 expression.

How can researchers troubleshoot weak or absent OR8J1 signal?

How do you interpret differences in results between OR8J1 antibodies from different sources?

Differences may result from:

• Epitope location: Antibodies targeting different regions (e.g., C-terminal vs. internal epitopes) may yield different patterns depending on protein conformation or processing .

• Antibody affinity: Different purification methods affect antibody affinity and sensitivity. Compare affinity-purified antibodies (such as ABIN7185374) against crude antisera.

• Cross-reactivity profiles: Antibodies may have different specificities for closely related olfactory receptors. Some OR8J1 antibodies have documented cross-reactivity with multiple species .

• Validation status: Consider the extent of validation performed. More extensively validated antibodies (with multiple application validations) generally provide more reliable results .

• Buffer formulation: Different preservatives or stabilizers may affect antibody performance under specific conditions.

To address discrepancies:

• Use multiple antibodies targeting different epitopes

• Compare results across multiple detection techniques (WB, IF, ELISA)

• Verify with functional assays or genetic approaches (siRNA, CRISPR)

What are the appropriate quantification methods for OR8J1 expression analysis?

For accurate quantification:

• Western blot densitometry:

  • Use housekeeping proteins (β-actin, GAPDH) as loading controls

  • Ensure signal is within linear range of detection

  • Normalize OR8J1 band intensity to loading control

  • Use biological replicates (n≥3) for statistical analysis

• Quantitative immunofluorescence:

  • Measure mean fluorescence intensity within defined regions of interest

  • Use same exposure settings for all samples

  • Include reference standards at known concentrations

  • Account for background autofluorescence

• ELISA-based quantification:

  • Generate standard curves using recombinant OR8J1 protein

  • Ensure samples fall within linear range of standard curve

  • Perform technical duplicates or triplicates

  • Calculate concentration based on absorbance values

How can OR8J1 antibodies be used in multiplex assays?

For co-localization and multi-parameter studies:

• Sequential immunostaining: When using multiple primary antibodies from the same host:

  • Apply first primary antibody at lower concentration

  • Block with anti-rabbit Fab fragments before applying second primary antibody

  • Use differently labeled secondary antibodies with non-overlapping emission spectra

• Antibody conjugation strategies:

  • Consider direct labeling of OR8J1 antibodies with fluorophores for multiplex applications

  • Use zenon labeling technology for rabbit antibodies

  • Employ tyramide signal amplification for low abundance targets

• Compatible techniques:

  • Combine with RNA in situ hybridization for simultaneous protein and mRNA detection

  • Use with proximity ligation assay (PLA) to detect protein-protein interactions

  • Integrate with single-cell analysis techniques

What are the considerations for using OR8J1 antibodies in cryoEM studies?

Based on recent advances in antibody-antigen structural studies :

• Antibody format: Use Fab fragments rather than whole IgG to reduce flexibility and improve resolution.

• Complex formation: Form OR8J1-antibody complexes at optimal ratios determined by titration experiments.

• Grid preparation: Consider detergent selection carefully for membrane proteins like OR8J1; mild detergents or nanodiscs may better preserve native structure.

• Image processing: Implement classification strategies to handle conformational heterogeneity of GPCRs.

• Model validation: Use computational approaches to validate antibody-antigen interfaces and assess model-to-map fit with Q-score analysis .

• Complementary methods: Combine with biochemical assays to confirm functional relevance of structural insights.

How do polyclonal OR8J1 antibodies compare with monoclonal alternatives?

What emerging technologies are enhancing OR8J1 antibody research?

Recent advances include:

• Active learning approaches: Machine learning algorithms are improving antibody-antigen binding prediction, potentially enhancing OR8J1 antibody design. These approaches can reduce experimental costs by 35% and accelerate learning by 28 steps compared to random baseline methods .

• CryoEM techniques: New methods for determining polyclonal antibody sequences directly from cryoEM maps are revolutionizing structural characterization of antibody-antigen complexes .

• Antibody engineering: Site-specific modifications are improving antibody properties for specialized applications:

  • Afucosylation of IgG1 antibodies influences pathogenicity in transplantation contexts

  • Enhanced conjugation chemistries for imaging applications

• Library-on-library screening: High-throughput methods where multiple antibodies are tested against multiple antigens simultaneously, providing comprehensive binding profiles and improving predictive models .

What is known about ectopic expression of OR8J1 in non-olfactory tissues?

While olfactory receptors are primarily expressed in nasal epithelium, mounting evidence suggests ectopic expression in other tissues:

• Detection approaches:

  • Use OR8J1 antibodies validated across multiple applications (WB, IF, ELISA)

  • Complement protein detection with mRNA analysis (RT-PCR, RNA-seq)

  • Validate findings with multiple antibodies targeting different epitopes

• Experimental considerations:

  • Include positive controls (olfactory epithelium or Jurkat cells)

  • Implement rigorous negative controls (secondary antibody only, peptide competition)

  • Use higher antibody concentrations (1:500 for WB, 1:100 for IF) when examining tissues with potentially low expression

• Functional validation:

  • Consider calcium imaging to assess receptor functionality

  • Utilize CRISPR-Cas9 knockout to confirm specificity of signals

  • Explore potential ligands using reporter assays

How can OR8J1 antibodies contribute to understanding evolutionary aspects of olfactory receptors?

OR8J1 antibodies can provide insights into evolutionary conservation:

• Cross-species reactivity: While most commercial OR8J1 antibodies are validated for human samples , some show cross-reactivity with multiple species including cow, dog, guinea pig, horse, mouse, rabbit, and rat . This can be leveraged to:

  • Compare receptor expression patterns across species

  • Examine structural conservation of epitopes

  • Investigate functional conservation through comparative studies

• Methodological approaches:

  • Test antibody cross-reactivity systematically across species

  • Use increasing antibody concentrations for species with lower epitope homology

  • Combine with sequence analysis and phylogenetic studies

• Research applications:

  • Map OR8J1 expression across homologous tissues in different species

  • Investigate selective pressures on olfactory receptor evolution

  • Examine potential neofunctionalization in different species